Physician profile
Parul Doshi
NPI 1114967510
$2,155.00
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,723 · 2020: $195 · 2021: $23.01 · 2023: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $461.70 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $216.69 | 2019-2020 | |
| Gilead Sciences, INC. | $215.90 | 2019 | |
| Inari Medical, INC. | $214.29 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.72 | 2019-2020 | |
| Amgen INC. | $162.86 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $149.12 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.11 | 2019 | |
| Alexion Pharmaceuticals, INC. | $104.56 | 2019-2021 | |
| Ekos Corporation | $75.00 | 2019 | |
| Astellas Pharma US INC | $67.96 | 2019-2020 | |
| Lilly USA, LLC | $47.17 | 2019-2020 | |
| Amarin Pharma, INC. | $37.16 | 2019-2020 | |
| Novo Nordisk INC | $31.15 | 2019 | |
| Allergan, INC. | $29.58 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $27.55 | 2019-2020 | |
| Abbott Laboratories | $14.51 | 2019 | |
| Shire North American Group INC | $13.16 | 2019 | |
| Circassia INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.